3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
6
Neoplasms
6
Cancer Pain
3
Marijuana Abuse
2
Neuralgia
1
Multiple Sclerosis
1
Diabetes Mellitus
1
Chronic Pain
1
Interventions
Fentanyl
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
ziconotide
1
nabiximols
1
morphine, naltrexone combination
1
Tapentadol
1
Sufentanil
1
Naltrexone
1
Morphine
1
Ketamine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Chronic Pain
×
nabiximols
×
Clear all
NCT03522467
2019-09-25
COPE
Aurora Cannabis Inc
Phase 2
Unknown
40 enrolled